Header Logo

Nancy Reau

TitleProfessor
InstitutionRush University, Rush Medical College
DepartmentHepatology
AddressChicago IL 60612
vCardDownload vCard

    Collapse Overview 
    Collapse overview
    My Scopus ID is 15756529900.

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Malhi H, Brown RS, Lim JK, Reau N, Tapper EB, Wong CC, Gores GJ. Precipitous changes in nomenclature and definitions-NAFLD becomes SLD: Implications for and expectations of AASLD journals. Liver Transpl. 2023 12 01; 29(12):1262-1263. PMID: 37941408.
      Citations:    
    2. Post Z, Reau N. What Is the Real Epidemiology of Hepatitis D Virus and Why so Many Mixed Messages? Clin Liver Dis. 2023 11; 27(4):973-984. PMID: 37778780.
      Citations:    
    3. Cavazos K, Eswaran S, Maidlow C, Keklik Karadag F, Idilman R, Idilman I, Miller I, Shammo J, Reau N, Ustun C. Liver fibrosis and its response to avapritinib in 2 patients with systemic mastocytosis. Blood Adv. 2022 10 25; 6(20):5630-5633. PMID: 35839085.
      Citations:    
    4. Reau N, Munoz SJ, Schiano T. Liver Disease During Pregnancy. Am J Gastroenterol. 2022 10 01; 117(10S):44-52. PMID: 36194033.
      Citations:    
    5. Kim M, Hui KM, Shi M, Reau N, Aloman C. Differential expression of hepatic cancer stemness and hypoxia markers in residual cancer after locoregional therapies for hepatocellular carcinoma. Hepatol Commun. 2022 11; 6(11):3247-3259. PMID: 36097402.
      Citations:    
    6. Reau N, Sulkowski MS, Thomas E, Sundaram V, Xu Q, Cheng WH, Marx SE, Hayes OA, Manthena SR, Chirikov V, Dylla DE, Brooks H, Carabino JM, Saab S. Epidemiology and Clinical Characteristics of Individuals with Hepatitis C Virus Infection in the United States, 2017-2019. Adv Ther. 2021 12; 38(12):5777-5790. PMID: 34704194.
      Citations:    
    7. Van J, Reau N. Disseminated AIDS-Related Kaposi Sarcoma Immune Reconstitution Inflammatory Syndrome With Infiltrative Liver Disease. ACG Case Rep J. 2021 Sep; 8(9):e00660. PMID: 34646902.
      Citations:    
    8. Van J, Aloman C, Reau N. Potential Bias and Misconceptions in Liver Transplantation for Alcohol- and Obesity-Related Liver Disease. Am J Gastroenterol. 2021 10 01; 116(10):2089-2097. PMID: 34193797.
      Citations:    
    9. Kushner T, Reau N. Had Anyone Considered the Donors? Fertility and Pregnancy Outcomes Among Female Living Donors. Liver Transpl. 2021 09; 27(9):1235-1236. PMID: 34118122.
      Citations:    
    10. McGuire FH, Andr? K, Bradsher ML, Harrison D, Sterling RK, Reddy KR, Serper M, Golin CE, Reau N, Lim JK, Nelson DR, Sarkar S, Evon DM. Willingness to participate in research among black patients with liver disease: A national cross-sectional study. J Viral Hepat. 2021 07; 28(7):982-993. PMID: 33665897.
      Citations:    
    11. Serper M, Evon DM, Amador J, Stewart PW, Sarkar S, Lok AS, Sterling RK, Reeve BB, Golin CE, Rajender Reddy K, Lim JK, Reau N, Nelson DR, Di Bisceglie AM, Fried MW. Patient-reported outcomes 12?months after hepatitis C treatment with direct-acting antivirals: Results from the PROP UP study. Liver Int. 2021 04; 41(4):692-704. PMID: 33387381.
      Citations:    
    12. Hamid S, Alvares da Silva MR, Burak KW, Chen T, Drenth JPH, Esmat G, Gaspar R, LaBrecque D, Lee A, Macedo G, McMahon B, Ning Q, Reau N, Sonderup M, van Leeuwen DJ, Armstrong D, Yurdaydin C. WGO Guidance for the Care of Patients With COVID-19 and Liver Disease. J Clin Gastroenterol. 2021 01; 55(1):1-11. PMID: 33230011.
      Citations:    
    13. Asselah T, Zeuzem S, Reau N, Hwang P, Long J, Talwani R, Robertson MN, Haber BA. Efficacy and safety of elbasvir/grazoprevir for 12 weeks in people with hepatitis C virus infection aged 35 years or younger compared with older people: a retrospective integrated analysis. Curr Med Res Opin. 2020 08; 36(8):1325-1332. PMID: 32459122.
      Citations:    
    14. Chaillon A, Rand EB, Reau N, Martin NK. Cost-effectiveness of Universal Hepatitis C Virus Screening of Pregnant Women in the United States. Clin Infect Dis. 2019 11 13; 69(11):1888-1895. PMID: 30689769.
      Citations:    
    15. Orekondy N, Cafardi J, Kushner T, Reau N. HCV in Women and Pregnancy. Hepatology. 2019 11; 70(5):1836-1840. PMID: 31135999.
      Citations:    
    16. Kushner T, Cafardi J, Reau N. Considering direct-acting antivirals to cure hepatitis C virus during pregnancy: is this the last treatment frontier? Ther Adv Infect Dis. 2019 Jan-Dec; 6:2049936119838229. PMID: 30984395.
      Citations:    
    17. Ma K, Berger D, Reau N. Liver Diseases During Pregnancy. Clin Liver Dis. 2019 05; 23(2):345-361. PMID: 30947881.
      Citations:    
    18. Reau N, Kwo PY, Rhee S, Brown RS, Agarwal K, Angus P, Gane E, Kao JH, Mantry PS, Mutimer D, Reddy KR, Tran TT, Hu YB, Gulati A, Krishnan P, Dumas EO, Porcalla A, Shulman NS, Liu W, Samanta S, Trinh R, Forns X. Glecaprevir/Pibrentasvir Treatment in Liver or Kidney Transplant Patients With Hepatitis C Virus Infection. Hepatology. 2018 10; 68(4):1298-1307. PMID: 29672891.
      Citations:    
    19. VanWagner LB, Reau N. Clinical Liver Disease: Introducing hot topics in hepatology. Clin Liver Dis (Hoboken). 2018 Feb; 11(2):33-34. PMID: 30147866.
      Citations:    
    20. Evon DM, Amador J, Stewart P, Reeve BB, Lok AS, Sterling RK, Di Bisceglie AM, Reau N, Serper M, Sarkar S, Lim JK, Golin CE, Fried MW. Psychometric properties of the PROMIS short form measures in a U.S. cohort of 961 patients with chronic hepatitis C prescribed direct acting antiviral therapy. Aliment Pharmacol Ther. 2018 Apr; 47(7):1001-1011. PMID: 29377191.
      Citations:    
    21. Reau N, Nelson DR. HBV reactivation after HCV eradication: Deja Vu. Liver Int. 2017 07; 37(7):1088. PMID: 28635166.
      Citations:    
    22. Reau NS. Pangenotypic regimens and the next generation hepatitis C virus therapy. Clin Liver Dis (Hoboken). 2017 Jun; 9(6):131-133. PMID: 30992976.
      Citations:    
    23. Behara R, Reau N. Updates on hepatitis C virus therapy in the direct-acting antiviral era. Curr Opin Gastroenterol. 2017 May; 33(3):115-119. PMID: 28350558.
      Citations:    
    24. Lawitz E, Reau N, Hinestrosa F, Rabinovitz M, Schiff E, Sheikh A, Younes Z, Herring R, Reddy KR, Tran T, Bennett M, Nahass R, Yang JC, Lu S, Dvory-Sobol H, Stamm LM, Brainard DM, McHutchison JG, Pearlman B, Shiffman M, Hawkins T, Curry M, Jacobson I. Efficacy of Sofosbuvir, Velpatasvir, and GS-9857 in Patients With?Genotype 1 Hepatitis C Virus Infection in an Open-Label, Phase 2 Trial. Gastroenterology. 2016 11; 151(5):893-901.e1. PMID: 27486034.
      Citations:    
    25. Gaetano JN, Micic D, Aronsohn A, Reddy G, Te H, Reau NS, Jensen D. The benefit of paracentesis on hospitalized adults with cirrhosis and ascites. J Gastroenterol Hepatol. 2016 May; 31(5):1025-30. PMID: 26642977.
      Citations:    
    26. Tran TT, Ahn J, Reau NS. ACG Clinical Guideline: Liver Disease and Pregnancy. Am J Gastroenterol. 2016 Feb; 111(2):176-94; quiz 196. PMID: 26832651.
      Citations:    
    27. Teriaky A, Reau N. Evaluation of Hepatitis C Patients in the Direct-Acting Antiviral Era. Clin Liver Dis. 2015 Nov; 19(4):591-604, v. PMID: 26466649.
      Citations:    
    28. Desai AP, Satoskar R, Appannagari A, Reddy KG, Te HS, Reau N, Meltzer DO, Jensen D. Co-management between hospitalist and hepatologist improves the quality of care of inpatients with chronic liver disease. J Clin Gastroenterol. 2014 Apr; 48(4):e30-6. PMID: 24100752.
      Citations:    
    29. Reau NS, Jensen DM. Sticker shock and the price of new therapies for hepatitis C: is it worth it? Hepatology. 2014 Apr; 59(4):1246-9. PMID: 24493069.
      Citations:    
    30. Reau N. Finding the needle in the haystack: predicting mortality in pregnancy-related liver disease. Clin Gastroenterol Hepatol. 2014 Jan; 12(1):114-6. PMID: 23962550.
      Citations:    
    31. Satoskar R, Reau N. Potential consequences of healthcare recommendations: a focus on the U.S. Preventive Services Task Force. Hepatology. 2013 Jul; 58(1):422-7. PMID: 23460345.
      Citations:    
    32. Aronsohn A, Reau N. Long-term outcomes after treatment with interferon and ribavirin in HCV patients. J Clin Gastroenterol. 2009 Aug; 43(7):661-71. PMID: 19448563.
      Citations:    
    33. Sauk J, Jensen DM, Mohanty SR, Reau N, Reddy KG, Te HS. Lack of Efficacy of Pegylated Interferon Monotherapy for Hepatitis C in Patients With End-Stage Renal Disease on Dialysis. Gastroenterol Hepatol (N Y). 2006 Jul; 2(7):504-508. PMID: 28289353.
      Citations:    
    Reau's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (147)
    Explore
    _
    Co-Authors (2)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _